A detailed history of Dakota Wealth Management transactions in Novartis Ag stock. As of the latest transaction made, Dakota Wealth Management holds 6,514 shares of NVS stock, worth $720,187. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,514
Previous 6,446 1.05%
Holding current value
$720,187
Previous $686,000 9.18%
% of portfolio
0.02%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$106.13 - $120.89 $7,216 - $8,220
68 Added 1.05%
6,514 $749,000
Q2 2024

Jul 19, 2024

SELL
$92.57 - $107.37 $13,052 - $15,139
-141 Reduced 2.14%
6,446 $686,000
Q1 2024

Apr 24, 2024

SELL
$95.27 - $108.47 $163,673 - $186,351
-1,718 Reduced 20.69%
6,587 $637,000
Q4 2023

Jan 30, 2024

SELL
$92.27 - $101.54 $12,087 - $13,301
-131 Reduced 1.55%
8,305 $838,000
Q3 2023

Oct 23, 2023

BUY
$94.73 - $105.13 $133,000 - $147,602
1,404 Added 19.97%
8,436 $859,000
Q2 2023

Jul 31, 2023

SELL
$92.52 - $104.91 $10,269 - $11,645
-111 Reduced 1.55%
7,032 $709,000
Q1 2023

Apr 14, 2023

SELL
$80.03 - $92.81 $30,571 - $35,453
-382 Reduced 5.08%
7,143 $657,000
Q4 2022

Feb 07, 2023

SELL
$75.55 - $92.52 $9,821 - $12,027
-130 Reduced 1.7%
7,525 $682,000
Q3 2022

Nov 10, 2022

BUY
$74.61 - $87.26 $95,873 - $112,129
1,285 Added 20.17%
7,655 $582,000
Q2 2022

Aug 05, 2022

BUY
$80.52 - $93.75 $120,860 - $140,718
1,501 Added 30.83%
6,370 $538,000
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $14,820 - $16,764
185 Added 3.95%
4,869 $427,000
Q4 2021

Feb 10, 2022

SELL
$79.7 - $88.13 $19,845 - $21,944
-249 Reduced 5.05%
4,684 $410,000
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $817 - $951
-10 Reduced 0.2%
4,933 $403,000
Q2 2021

Aug 02, 2021

BUY
$85.24 - $94.15 $28,299 - $31,257
332 Added 7.2%
4,943 $451,000
Q1 2021

May 10, 2021

BUY
$83.5 - $98.47 $835 - $984
10 Added 0.22%
4,611 $394,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $12,022 - $14,542
-154 Reduced 3.24%
4,601 $434,000
Q3 2020

Nov 04, 2020

BUY
$82.14 - $91.0 $8,542 - $9,464
104 Added 2.24%
4,755 $414,000
Q1 2020

Apr 29, 2020

SELL
$70.67 - $99.01 $5,300 - $7,425
-75 Reduced 1.59%
4,651 $383,000
Q4 2019

Feb 06, 2020

SELL
$84.35 - $95.37 $7,591 - $8,583
-90 Reduced 1.87%
4,726 $448,000
Q3 2019

Nov 14, 2019

BUY
$85.54 - $94.26 $16,765 - $18,474
196 Added 4.24%
4,816 $419,000
Q2 2019

Aug 07, 2019

SELL
$75.4 - $92.8 $12,139 - $14,940
-161 Reduced 3.37%
4,620 $421,000
Q1 2019

Apr 18, 2019

BUY
$75.32 - $86.15 $7,983 - $9,131
106 Added 2.27%
4,781 $422,000
Q4 2018

Jan 22, 2019

SELL
$73.66 - $82.02 $2,209 - $2,460
-30 Reduced 0.64%
4,675 $402,000
Q3 2018

Nov 07, 2018

SELL
$66.94 - $77.43 $19,412 - $22,454
-290 Reduced 5.81%
4,705 $406,000
Q2 2018

Aug 09, 2018

BUY
$64.91 - $73.36 $324,225 - $366,433
4,995 New
4,995 $378,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Dakota Wealth Management Portfolio

Follow Dakota Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.